2.4.2.3: uridine phosphorylase
This is an abbreviated version!
For detailed information about uridine phosphorylase, go to the full flat file.
Word Map on EC 2.4.2.3
-
2.4.2.3
-
pyrimidine
-
nucleoside
-
thymidine
-
uracil
-
5-fluorouracil
-
phosphorolysis
-
salvage
-
orotate
-
phosphoribosyltransferase
-
phosphorylases
-
thymidylate
-
fluoropyrimidine
-
udp
-
5'-deoxy-5-fluorouridine
-
5-fluoro-2'-deoxyuridine
-
dihydropyrimidine
-
acyclonucleoside
-
5-fluorouridine
-
ribose-1-phosphate
-
capecitabine
-
5-methyluridine
-
dthdpase
-
fdurd
-
orotidine
-
dihydrouracil
-
uridine-cytidine
-
mete
-
diagnostics
-
medicine
-
synthesis
-
drug development
- 2.4.2.3
- pyrimidine
- nucleoside
- thymidine
- uracil
- 5-fluorouracil
-
phosphorolysis
-
salvage
- orotate
-
phosphoribosyltransferase
- phosphorylases
- thymidylate
-
fluoropyrimidine
- udp
- 5'-deoxy-5-fluorouridine
- 5-fluoro-2'-deoxyuridine
- dihydropyrimidine
- acyclonucleoside
- 5-fluorouridine
- ribose-1-phosphate
- capecitabine
- 5-methyluridine
- dthdpase
-
fdurd
- orotidine
- dihydrouracil
-
uridine-cytidine
-
mete
- diagnostics
- medicine
- synthesis
- drug development
Reaction
Synonyms
apUP, EC 2.4.2.23, L-UrdPase, More, PcUP1, PcUP2, phosphorylase, uridine, pynpase, pyrimidine nucleoside phosphorylase, pyrimidine phosphorylase, pyrimidine/purine nucleoside phosphorylase, StUPh, udp, UDRPase
ECTree
Advanced search results
Source Tissue
Source Tissue on EC 2.4.2.3 - uridine phosphorylase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
-
colon 26 tumor cells transplanted in BALB/c mice
UPP1 is significantly upregulated in glioma, especially in glioblastoma
UPP1 is significantly upregulated in glioma, especially in glioblastoma
UPP1 expression is significantly downregulated in thyroid cancer
-
N-butyl-N-(4-hydoxybutyl) nitrosamine (BBN) treatment for 12 weeks induces invasive cancer development in mice
-
N-butyl-N-(4-hydoxybutyl) nitrosamine (BBN) treatment for 12 weeks induces superficial cancer development in rats
-
12, 16 and 20 weeks after initiation of BBN treatment: higher PyNpase level in invasive carcinoma and hyperplasia compared to controls
-
12 weeks after initiation of BBN treatment: higher PyNpase level in superficial cancer and hyperplasia compared to controls, 16 and 20 weeks after initiation of BBN treatment: higher PyNpase level in superficial cancer but not in hyperplasia compared to controls
-
negative correlation between UPase expression and the clinical outcome of breast cancer